Chen Shuli, Hu Jie, Zhang Di, Li Zihan, Zheng Zhiyun, Gui Shuangying, He Ning
Department of Pharmaceutics, College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Institute of Pharmaceutics, Anhui Academy of Chinese Medical Sciences, Hefei, China.
J Biomater Sci Polym Ed. 2025 Oct;36(15):2216-2236. doi: 10.1080/09205063.2025.2499285. Epub 2025 May 12.
In trauma resuscitation, rapid hemostasis is a top priority for rescuing patients from the risk of hemorrhagic shock and infection. Traditional hemostatic materials are not effective for hemostasis and have some limitations. We added "Duanxue Liu" saponin A (Clinodiside A) to a hemostatic sponge based on carboxymethyl chitosan (CMCS) and gelatin to improve its hemostatic effect. Clinodiside A has hemostatic, anti-inflammatory and antibacterial effects, and its preparation into a sponge can help to improve the coagulation ability, prolong the action time of the drug, increase the bioavailability and improve the stability of the drug. The results showed that the prepared hemostatic sponge had a honeycomb porous structure, strong shape recovery ability, good water absorption and porosity, low hemolysis rate and no obvious cytotoxicity. The results of in vitro coagulation test showed that the coagulation time of GOC, GOC-1, GOC-2 and GOC-3 sponges was shorter than that of the control group, and the BCI index was much lower than that of the commercially available sponges. In the tail-breaking experiment of SD rats, GOC-3 showed the lowest blood loss of 0.2549 g and the hemostasis time of 55 s. In the experiment of rabbit ear artery, GOC-3 showed the lowest blood loss of 98.75 mg and the hemostasis time of 95 s. This indicates that the Clinique A hemostatic sponges have highly efficient hemostatic properties. Therefore, the prepared CMCS/Gel/Clinodiside A sponge has a good application prospect as a hemostatic dressing.
在创伤复苏中,快速止血是将患者从失血性休克和感染风险中解救出来的首要任务。传统止血材料止血效果不佳且存在一些局限性。我们将“断血流”皂苷A(clinodiside A)添加到基于羧甲基壳聚糖(CMCS)和明胶的止血海绵中,以提高其止血效果。Clinodiside A具有止血、抗炎和抗菌作用,将其制成海绵有助于提高凝血能力、延长药物作用时间、增加生物利用度并提高药物稳定性。结果表明,制备的止血海绵具有蜂窝状多孔结构、较强的形状恢复能力、良好的吸水性和孔隙率、低溶血率且无明显细胞毒性。体外凝血试验结果表明,GOC、GOC-1、GOC-2和GOC-3海绵的凝血时间均短于对照组,BCI指数远低于市售海绵。在SD大鼠断尾实验中,GOC-3的失血量最低,为0.2549 g,止血时间为55 s。在兔耳动脉实验中,GOC-3的失血量最低,为98.75 mg,止血时间为95 s。这表明Clinique A止血海绵具有高效的止血性能。因此,制备的CMCS/Gel/Clinodiside A海绵作为止血敷料具有良好的应用前景。